Related Experiment Video

Updated: Aug 20, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Towards defining heart failure in adults with congenital heart disease

Aidan P Bolger1, Michael A Gatzoulis

  • 1National Heart and Lung Institute, Imperial College, London, UK. a.bolger@imperial.ac.uk

International Journal of Cardiology
|December 14, 2004
PubMed

Insights

Heart failure in congenital heart disease (CHD) arises from anatomical distortions affecting cardiac function. This study examines clinical, neurohormonal, and cellular factors to redefine heart failure for CHD patients.

Area of Science:

  • Cardiology
  • Physiology

Background:

  • Myocardial injury alters cardiac geometry, pressure, and blood flow, leading to heart failure.
  • Heart failure is typically associated with ischemic heart disease and dilated cardiomyopathy.
  • Congenital heart disease (CHD) patients have inherent anatomical distortions predisposing them to heart failure.

Purpose of the Study:

  • To explore clinical and neurohormonal manifestations of heart failure in CHD.
  • To investigate cellular-level events contributing to heart failure in CHD.
  • To propose a population-specific definition of heart failure for CHD patients.

Main Methods:

  • Review of existing clinical and neurohormonal data in CHD patients with heart failure.
  • Exploration of cellular mechanisms underlying heart failure in CHD.
  • Analysis of cardiac anatomy and its impact on hemodynamic forces.

Main Results:

  • Patients with CHD experience heart failure due to anatomical abnormalities.
  • Neurohormonal activation is a key feature of heart failure in this population.
  • Cellular-level changes contribute significantly to the pathophysiology of heart failure in CHD.

Conclusions:

  • Heart failure in CHD requires a definition beyond traditional parameters.
  • Understanding cellular and anatomical factors is crucial for managing heart failure in CHD.
  • Further research into cellular mechanisms can refine heart failure diagnosis and treatment in CHD.

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

A Modified Technique for Transverse Aortic Constriction in Mice04:52

A Modified Technique for Transverse Aortic Constriction in Mice

Published on: August 18, 2022

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...